Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Información
- DOI:
- https://doi.org/10.1002/14651858.CD003053.pub5Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 16 mayo 2012see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Ginecología y fertilidad
- Copyright:
-
- Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
JML ‐ primary literature search, initial assessment of trials and quality analysis, data collection, analysis, initial draft of full review (2003 version)
IF ‐ developing protocol, checking literature search, secondary assessment of trials and quality analysis (blinded), reviewing data collection and analysis, revising first draft of full review (2003 version)
RN ‐ developing protocol, final arbiter to resolve differences in quality assessment between other reviewers, finalising final review, content and Cochrane expert (2003 version)
TT ‐ literature search, assessment of trials, data collection and analysis in the update period (January 2003 to November 2010). Preparation of the revised review (2008 and 2010 version).
EY ‐ checking literature search and secondary assessment of trials (2008 and 2010 version)
AB ‐ secondary assessment of trials and quality analysis. Revising and finalizing the final revised review (2008 and 2010 version)
Sources of support
Internal sources
-
Peninsula Medical School, UK.
-
University of Adelaide, Australia.
-
Department of Reproductive Medicine, Leeds, UK.
External sources
-
No sources of support supplied
Declarations of interest
None declared
Acknowledgements
We would like to thank the corresponding authors of the following trials who took time to respond to our requests for further data, some of whom took the trouble to perform repeat analyses for us:
Chou 2003; Fleming 2002; Glintborg 2005; Hoeger 2004; Hwu 2005; Jakubowicz 2001; Ladson 2011; Legro 2007; Lord 2006; Malkawi 2002; Moghetti 2000; Nestler 1997; Nestler 1999; Ng 2001; Rautio 2006; Sturrock 2002; Trolle 2007; Vandermolen 2001; Yarali 2002.
We would also like to thank the Cochrane Menstrual Disorders and Subfertility Review Group in Auckland, and in particular their Managing Editor (to 2011) Jane Clarke, for all their help and support. We are also grateful to Rafael Perera of the UK Cochrane Centre for statistical advice.
Version history
| Published | Title | Stage | Authors | Version |
| 2017 Nov 28 | Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility | Review | Lara C Morley, Thomas Tang, Ephia Yasmin, Robert J Norman, Adam H Balen | |
| 2012 May 16 | Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility | Review | Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin, Adam H Balen | |
| 2010 Jan 20 | Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility | Review | Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin, Adam H Balen | |
| 2009 Oct 07 | Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility | Review | Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin, Adam H Balen | |
| 2009 Jul 08 | Insulin‐sensitising drugs for polycystic ovary syndrome | Review | Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin, Adam H Balen | |
| 2003 Apr 22 | Insulin‐sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D‐chiro‐inositol) for polycystic ovary syndrome | Review | Thomas Tang, Robert J Norman, Adam H Balen, Jonathan M Lord | |
Differences between protocol and review
In the updated review, the title was changed from 'Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for polycystic ovary syndrome' to 'Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility'.
The outcome measures were restructured. One new comparison was added (metformin versus clomiphene).
Studies using troglitazone were excluded.
